Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition.

Niemann-Pick type C (NP-C) disease is a devastating developmental disorder with progressive and fatal neurodegeneration. We have used a mouse model of Niemann-Pick type C (NP-C) disease to evaluate the effects of direct intracerebral transplantation of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) on the progression of neurological disease in this order. Here, we show that hUCB-MSCs transplantation into NP-C mice prevents the loss of Purkinje neurons and inhibits cerebellar apoptotic cell death. Interestingly, these effects were associated with the modulation of inflammatory responses, as evidenced by increased anti-inflammatory cytokine IL-10, and reduced abnormal astrocytic activation. Furthermore, our results show that the hUCB-MSCs transplantation reduced the cholesterol accumulation level in neurons in NP-C mice compared with sham-transplanted animals. This study provides the first evidence that hUCB-MSCs can improve neurological symptoms in NP-C disease, suggesting it as a potential therapeutic agent against neurodegenerative diseases.

[1]  L. Jen,et al.  Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model , 2009, Experimental Neurology.

[2]  Yuan Yang,et al.  The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro , 2009, Immunology.

[3]  A. Galione,et al.  Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium , 2008, Nature Medicine.

[4]  Y. Torrente,et al.  Mesenchymal Stem Cell Transplantation for Neurodegenerative Diseases , 2008, Cell transplantation.

[5]  L. Bernier,et al.  Gene set enrichment analyses revealed several affected pathways in Niemann-pick disease type C fibroblasts. , 2007, DNA and cell biology.

[6]  S. Dunnett,et al.  Stem cell transplantation for Huntington's disease , 2007, Experimental Neurology.

[7]  Fred H. Gage,et al.  Therapeutic interventions after spinal cord injury , 2006, Nature Reviews Neuroscience.

[8]  Hoon Han,et al.  Successful Stem Cell Therapy Using Umbilical Cord Blood‐Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal Model , 2006, Stem cells.

[9]  Robert H Miller.  The promise of stem cells for neural repair , 2006, Brain Research.

[10]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[11]  JoAnn Buchanan,et al.  Cell-Autonomous Death of Cerebellar Purkinje Neurons with Autophagy in Niemann-Pick Type C Disease , 2005, PLoS genetics.

[12]  S. Goldman.  Stem and progenitor cell–based therapy of the human central nervous system , 2005, Nature Biotechnology.

[13]  Y. Hirabayashi,et al.  Neuroglial activation in Niemann–Pick Type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells , 2005, Neuroscience Letters.

[14]  배재성,et al.  Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick Type C mice , 2005 .

[15]  Rabi Simantov,et al.  Stem cells may reshape the prospect of Parkinson's disease therapy. , 2005, Brain research. Molecular brain research.

[16]  S. Walkley,et al.  Consequences of NPC1 and NPC2 loss of function in mammalian neurons. , 2004, Biochimica et biophysica acta.

[17]  Y. Ioannou,et al.  The NPC1 protein: structure implies function. , 2004, Biochimica et biophysica acta.

[18]  C. Ha,et al.  Mesenchymal stem/progenitor cells developed in cultures from UC blood. , 2004, Cytotherapy.

[19]  R. Dwek,et al.  Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport* , 2004, Journal of Biological Chemistry.

[20]  Danielle A. Simmons,et al.  Postnatal development of inflammation in a murine model of Niemann–Pick type C disease: immunohistochemical observations of microglia and astroglia , 2003, Experimental Neurology.

[21]  E. Schuchman,et al.  Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of Niemann-Pick disease. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  C. Ferrari,et al.  Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease , 2003, The European journal of neuroscience.

[23]  K. Broman,et al.  Discrete Gene Loci Regulate Neurodegeneration, Lymphocyte Infiltration, and Major Histocompatibility Complex Class II Expression in the CNS , 2003, The Journal of Neuroscience.

[24]  P. Sanberg,et al.  Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. , 2003, Journal of hematotherapy & stem cell research.

[25]  E. Hirsch,et al.  The Role of Glial Reaction and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[26]  E. Ikonen,et al.  Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease , 2002, Behavioural Brain Research.

[27]  D. German,et al.  Neurodegeneration in the Niemann–Pick C mouse: glial involvement , 2002, Neuroscience.

[28]  N. Fisk,et al.  Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. , 2001, Blood.

[29]  M. Mattson,et al.  Stem cells and aging: expanding the possibilities , 2001, Mechanisms of Ageing and Development.

[30]  A. Colangelo,et al.  Interleukin-10 Prevents Glutamate-Mediated Cerebellar Granule Cell Death by Blocking Caspase-3-Like Activity , 2001, The Journal of Neuroscience.

[31]  S. Walkley,et al.  Neurons in Niemann‐Pick Disease Type C Accumulate Gangliosides as Well as Unesterified Cholesterol and Undergo Dendritic and Axonal Alterations , 2001, Journal of neuropathology and experimental neurology.

[32]  D. Burns,et al.  Cholesterol Is Sequestered in the Brains of Mice with Niemann‐Pick Type C Disease but Turnover Is Increased , 2000, Journal of neuropathology and experimental neurology.

[33]  P. Conget,et al.  Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.

[34]  G. Feuerstein,et al.  Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.

[35]  M. Mayo,et al.  Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.

[36]  M. C. Acosta,et al.  Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. , 1999, Journal of neurotrauma.

[37]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  T. Marunouchi,et al.  Interleukin‐10 Inhibits Both Production of Cytokines and Expression of Cytokine Receptors in Microglia , 1999, Journal of neurochemistry.

[39]  A. Faden,et al.  Interleukin-10 Improves Outcome and Alters Proinflammatory Cytokine Expression after Experimental Traumatic Brain Injury , 1998, Experimental Neurology.

[40]  M. Umeda,et al.  Lysenin, a Novel Sphingomyelin-specific Binding Protein* , 1998, The Journal of Biological Chemistry.

[41]  G. Levi,et al.  Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide , 1998, Progress in Neurobiology.

[42]  R. Bertorelli,et al.  Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice. , 1997, European journal of pharmacology.

[43]  S. Walkley,et al.  GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C , 1997, Acta Neuropathologica.

[44]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[45]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[46]  G. Hunninghake,et al.  Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. , 1995, The American journal of physiology.

[47]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[48]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.

[49]  H. Konno,et al.  IDENTIFICATION OF THE NORMAL MICROGLIAL POPULATION IN HUMAN AND RODENT NERVOUS TISSUE USING LECTIN–HISTOCHEMISTRY , 1988, Neuropathology and applied neurobiology.

[50]  R. Brady,et al.  Niemann‐Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification: A collaborative study on 70 patients , 1988, Clinical genetics.

[51]  D. Roberts,et al.  The quantitative measurement of motor inco‐ordination in naive mice using an accelerating rotarod , 1968 .

[52]  N W DUNHAM,et al.  A note on a simple apparatus for detecting neurological deficit in rats and mice. , 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[53]  R. Proia,et al.  Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. , 2005, Molecular genetics and metabolism.

[54]  S. Murayama,et al.  Cerebellar degeneration in the Niemann-Pick type C mouse , 2004, Acta Neuropathologica.

[55]  D. Roberts,et al.  The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. , 1968, The Journal of pharmacy and pharmacology.